Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272 Grant US-10729672-B2 United States of America 04 Aug 2020
Method for treating gefitinib resistant cancer Grant US-10603314-B2 United States of America 31 Mar 2020
Method for treating gefitinib resistant cancer Grant US-10596162-B2 United States of America 24 Mar 2020
Antineoplastic combinations containing HKI-272 and vinorelbine Grant US-10111868-B2 United States of America 30 Oct 2018